XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://xconomy.com/boston/2019/02/28/ex-google-ceo-new-mit-college-could-help-shrink-a-i-talent-gap/60%Monthly2019-02-28 21:26
https://xconomy.com/seattle/2019/02/28/seattle-venture-capital-watch-modumetal-illumagear-haptx-more/60%Monthly2019-03-04 20:29
https://xconomy.com/seattle/2019/02/28/steve-reed-steps-down-as-ceo-of-idri-to-lead-two-spinout-companies/60%Monthly2019-02-28 20:30
https://xconomy.com/new-york/2019/02/28/immunomedics-ceo-michael-pehl-resigns/60%Monthly2019-02-28 20:28
https://xconomy.com/national/2019/02/28/7-tips-for-biotech-companies-seeking-capital-in-a-volatile-market/60%Monthly2019-02-28 15:16
https://xconomy.com/san-francisco/2019/02/28/ranis-robotic-pill-for-biologics-clears-first-hurdle-in-humans/60%Monthly2019-03-05 04:06
https://xconomy.com/detroit-ann-arbor/2019/02/28/carmera-toyota-research-institute-zoom-ahead-on-av-mapping-project/60%Monthly2019-02-28 13:35
https://xconomy.com/texas/2019/02/28/database-automation-software-maker-datical-adds-10m-for-new-hires/60%Monthly2019-02-27 20:56
https://xconomy.com/san-francisco/2019/02/28/with-191m-haul-maze-launches-to-tackle-genetic-diseases/60%Monthly2019-02-28 07:27
https://xconomy.com/boston/2019/02/27/kaleido-bio-downsizes-ipo-raises-75m-for-microbiome-drug-tests/60%Monthly2019-02-28 02:14
https://xconomy.com/texas/2019/02/27/atx-seed-ventures-raises-second-investment-fund-of-32-million/60%Monthly2019-02-28 01:19
https://xconomy.com/new-york/2019/02/27/bristol-myers-74b-celgene-buyout-faces-opposition-from-wellington/60%Monthly2019-02-28 17:20
https://xconomy.com/texas/2019/02/27/microsofts-m12-leads-21m-round-for-spyclouds-security-software/60%Monthly2019-03-06 14:41
https://xconomy.com/boston/2019/02/27/sarepta-touts-more-gene-therapy-data-snaps-up-myonexus-for-165m/60%Monthly2019-02-27 19:32
https://xconomy.com/national/2019/02/27/walmarts-store-no-8-acquires-aspectiva-to-bring-a-i-to-shopping/60%Monthly2019-02-27 15:43
https://xconomy.com/san-francisco/2019/02/27/early-stage-vc-firm-sorenson-ventures-closes-inaugural-fund-at-110m/60%Monthly2019-02-27 06:08
https://xconomy.com/boston/2019/02/27/blue-collar-career-site-jobcase-raises-100m-to-advocate-for-workers/60%Monthly2019-02-28 22:33
https://xconomy.com/national/2019/02/27/amazon-google-facebook-boosted-2018-tech-hiring-spree-in-u-s-hubs/60%Monthly2019-02-27 16:50
https://xconomy.com/boston/2019/02/27/blackstone-novartis-start-up-anthos-with-250m-and-a-heart-drug/60%Monthly2019-02-27 12:45
https://xconomy.com/national/2019/02/26/pharma-ceos-to-senate-we-will-lower-drug-prices-if-rebates-go-away/60%Monthly2019-02-27 00:35
https://xconomy.com/texas/2019/02/26/rapamycin-holdings-changes-name-to-emtora-biosciences-hires-new-ceo/60%Monthly2019-02-26 16:57
https://xconomy.com/new-york/2019/02/26/no-details-but-astrazeneca-touts-parp-drug-win-in-pancreatic-cancer/60%Monthly2019-02-26 14:10
https://xconomy.com/boston/2019/02/26/seeded-with-2-5m-sales-tech-firm-polis-is-coming-for-your-front-door/60%Monthly2019-02-26 13:46
https://xconomy.com/new-york/2019/02/26/oyster-point-gets-93m-to-clear-up-dry-eye-with-a-nasal-spray/60%Monthly2019-02-26 13:59
https://xconomy.com/texas/2019/02/26/port-san-antonio-considers-innovation-center-on-former-air-force-base/60%Monthly2019-02-26 13:47
https://xconomy.com/boston/2019/02/26/ginkgos-motif-launches-with-90m-for-animal-free-meat-milk-proteins/60%Monthly2019-02-26 23:16
https://xconomy.com/boston/2019/02/26/24m-lithium-ion-batteries-power-density-standard/60%Monthly2019-02-26 13:35
https://xconomy.com/texas/2019/02/26/new-funds-for-parkhub-neighborhood-goods-rabbet-more-tx-tech/60%Monthly2019-02-26 01:07
https://xconomy.com/detroit-ann-arbor/2019/02/26/mainstreet-mob-aims-the-spotlight-on-detroits-small-businesses/60%Monthly2019-02-25 20:17
https://xconomy.com/san-diego/2019/02/25/novartis-to-pay-150m-to-ionis-akcea-for-drug-to-slow-heart-disease/60%Monthly2019-02-26 01:20
https://xconomy.com/boston/2019/02/25/mobile-tech-affirmed-networks-38m-funding-5g-future-network/60%Monthly2019-02-25 19:26
https://xconomy.com/texas/2019/02/25/scaleworks-adds-80m-for-second-venture-equity-investment-fund/60%Monthly2019-02-25 18:31
https://xconomy.com/san-diego/2019/02/25/bill-mariss-vc-firm-section-32-raises-200m-for-second-fund/60%Monthly2019-02-25 17:31
https://xconomy.com/national/2019/02/25/roche-bets-4-8b-on-spark-therapeutics-and-the-future-of-gene-therapy/60%Monthly2019-02-25 14:10
https://xconomy.com/detroit-ann-arbor/2019/02/25/fintech-pitchfest-highlights-detroits-blockchain-crypto-activity/60%Monthly2019-02-22 19:29
https://xconomy.com/boston/2019/02/22/fda-staff-hammers-karyopharm-cancer-drug-on-safety-efficacy-concerns/60%Monthly2019-02-22 23:57
https://xconomy.com/boston/2019/02/22/alexions-rachelle-jacques-jumps-to-enzyvant-for-ceo-role/60%Monthly2019-02-22 18:31
https://xconomy.com/raleigh-durham/2019/02/22/innovate-bioharma-ceo-prior-resigns-chairman-laumas-steps-in/60%Monthly2019-02-28 22:48
https://xconomy.com/wisconsin/2019/02/22/exact-sciences-eyes-cologuard-market-expansion-after-landmark-year/60%Monthly2019-02-22 20:42
https://xconomy.com/boston/2019/02/22/voyager-therapeutics-abbvie-add-parkinsons-to-gene-therapy-pact/60%Monthly2019-02-22 15:33
https://xconomy.com/wisconsin/2019/02/22/wi-watchlist-rockwell-wellbe-generac-api-healthcare-more/60%Monthly2019-02-22 14:07
https://xconomy.com/national/2019/02/22/bio-roundup-nash-news-merck-strikes-digital-tokens-more/60%Monthly2019-02-22 16:03
https://xconomy.com/boston/2019/02/22/boston-tech-watch-thermo-fisher-in-china-1uphealth-anaqua-more/60%Monthly2019-03-26 14:03
https://xconomy.com/detroit-ann-arbor/2019/02/22/spatial-ais-geosocial-datasets-capture-a-communitys-personality/60%Monthly2019-02-21 20:05
https://xconomy.com/boston/2019/02/21/cerevel-therapeutics-taps-otsukas-sanchez-for-chief-medical-officer/60%Monthly2019-02-21 19:42
https://xconomy.com/texas/2019/02/21/molecular-templates-appoints-roger-waltzman-chief-medical-officer/60%Monthly2019-02-21 19:36
https://xconomy.com/boston/2019/02/21/qlik-attunity-deal-data-management-burlington-560m-deal-acquisition/60%Monthly2019-02-21 20:03
https://xconomy.com/texas/2019/02/21/notley-invests-in-divinc-accelerator-for-women-and-people-of-color/60%Monthly2019-02-21 18:56
https://xconomy.com/new-york/2019/02/21/merck-scooping-up-cancer-drug-developer-immune-design-for-300m/60%Monthly2019-02-21 16:39
https://xconomy.com/san-diego/2019/02/20/software-startup-portfolium-acquired-by-salt-lake-citys-instructure/60%Monthly2019-02-21 03:27
https://xconomy.com/seattle/2019/02/20/blaze-bio-raises-5m-to-help-surgeons-see-tumors-from-healthy-tissue/60%Monthly2019-02-27 18:20
https://xconomy.com/boston/2019/02/20/nutonomy-self-driving-autonomous-vehicles-boston-sun-glare-traffic-light/60%Monthly2019-02-20 20:04
https://xconomy.com/new-york/2019/02/20/starboard-ups-bristol-myers-stake-ahead-of-vote-on-celgene-deal/60%Monthly2019-02-20 17:55
https://xconomy.com/texas/2019/02/20/peloton-therapeutics-raises-150m-to-advance-kidney-cancer-therapy/60%Monthly2019-02-20 15:41
https://xconomy.com/san-francisco/2019/02/20/menlo-ventures-devotes-new-500m-fund-to-mid-stage-growth-companies/60%Monthly2019-02-20 01:37
https://xconomy.com/detroit-ann-arbor/2019/02/20/detroit-urban-solutions-seeks-to-amplify-the-regional-tech-ecosystem/60%Monthly2019-02-19 20:42
https://xconomy.com/texas/2019/02/19/gencure-plans-adult-stem-cell-lab-at-san-antonio-innovation-center/60%Monthly2019-02-19 23:09
https://xconomy.com/san-francisco/2019/02/19/former-avexis-exec-kamal-named-4d-molecular-chief-technical-officer/60%Monthly2019-02-19 21:35
https://xconomy.com/new-york/2019/02/19/xeroxs-wolfson-joins-quest-as-chief-information-and-digital-officer/60%Monthly2019-02-19 21:30
https://xconomy.com/detroit-ann-arbor/2019/02/19/amazon-leads-rivians-700m-round-hinting-at-possible-auto-ambitions/60%Monthly2019-02-19 22:23
https://xconomy.com/boston/2019/02/19/cloud-tech-firm-nasuni-takes-in-25m-in-telstra-led-funding-round/60%Monthly2019-02-19 20:46
https://xconomy.com/boston/2019/02/19/digital-guardian-taps-ca-technologies-cyber-exec-as-its-new-ceo/60%Monthly2019-02-19 17:37
https://xconomy.com/boston/2019/02/19/rapid7-raytheon-recorded-future-join-cyber-madness-in-boston-on-april-8/60%Monthly2019-03-04 13:10
https://xconomy.com/new-york/2019/02/19/with-new-data-intercept-on-track-for-first-ever-approved-nash-drug/60%Monthly2019-06-25 03:14
https://xconomy.com/boston/2019/02/15/stealth-bios-ipo-raises-78m-for-clinical-tests-of-mitochondrial-drugs/60%Monthly2019-02-15 22:16
https://xconomy.com/texas/2019/02/15/funds-for-richards-rainwater-new-cprit-executive-more-tx-tech/60%Monthly2019-02-15 19:06
https://xconomy.com/indiana/2019/02/15/bayer-snaps-up-rights-to-two-cancer-drugs-from-lillys-8b-loxo-deal/60%Monthly2019-02-15 18:42
https://xconomy.com/san-diego/2019/02/15/bill-maris-fund-section-32-notches-two-wins-with-life-science-exits/60%Monthly2019-02-16 03:26
https://xconomy.com/wisconsin/2019/02/15/google-confirms-new-madison-office-part-of-13b-national-expansion/60%Monthly2019-02-15 15:35
https://xconomy.com/detroit-ann-arbor/2019/02/15/stigma-is-going-away-cannabis-ip-is-thorny-but-not-impossible/60%Monthly2019-02-15 14:20
https://xconomy.com/boston/2019/02/15/boston-tech-watch-student-loans-google-in-kendall-square-more/60%Monthly2019-02-15 21:43
https://xconomy.com/national/2019/02/15/bio-roundup-trumps-scalps-policy-pressure-nash-crash-more/60%Monthly2019-02-15 12:02
https://xconomy.com/wisconsin/2019/02/15/wi-watchlist-flugen-propeller-health-gener8tor-ensync/60%Monthly2019-02-14 17:43
https://xconomy.com/national/2019/02/14/finding-true-love-can-be-ruff-but-this-startup-could-have-your-match/60%Monthly2019-02-15 13:55
https://xconomy.com/seattle/2019/02/14/polly-want-a-slack-plugin-seattle-enterprise-it-startup-raises-7m/60%Monthly2019-02-15 00:01
https://xconomy.com/boston/2019/02/14/nimbus-picks-janssens-tummino-for-chief-scientific-officer-post/60%Monthly2019-02-15 23:55
https://xconomy.com/texas/2019/02/14/velocitytx-lands-city-grant-for-innovation-center-redevelopment/60%Monthly2019-02-19 20:31
https://xconomy.com/boston/2019/02/14/ge-boston-hq-scale-back-office-massachusetts/60%Monthly2019-02-15 14:14
https://xconomy.com/new-york/2019/02/14/its-not-you-its-your-officials-amazon-cancels-hq-plan-for-nyc/60%Monthly2019-02-15 14:54
https://xconomy.com/national/2019/02/14/passage-bio-gets-116m-as-wilson-yamada-team-up-on-gene-therapy-again/60%Monthly2019-02-14 21:08
https://xconomy.com/san-diego/2019/02/14/plant-breeding-biotech-cibus-delays-ipo-citing-market-conditions/60%Monthly2019-02-14 19:57
https://xconomy.com/boston/2019/02/14/skyhawk-therapeutics-appoints-guerciolini-chief-medical-officer/60%Monthly2019-02-16 00:00
https://xconomy.com/boston/2019/02/14/tcr%c2%b2s-ipo-raises-75m-to-bring-cancer-cell-therapy-to-solid-tumors/60%Monthly2019-02-14 16:27
https://xconomy.com/seattle/2019/02/13/xnor-ai-makes-solar-powered-computer-chip-to-crunch-learn-from-data/60%Monthly2019-02-14 00:49
https://xconomy.com/national/2019/02/13/dbv-rejoins-peanut-allergy-treatment-race-but-aimmune-takes-the-lead/60%Monthly2019-02-14 17:39
https://xconomy.com/san-diego/2019/02/13/mission-edge-taps-10-businesses-for-social-enterprise-accelerator/60%Monthly2019-02-13 21:49
https://xconomy.com/new-york/2019/02/13/johnson-johnson-to-buy-robotics-startup-auris-health-for-3-4b/60%Monthly2019-02-13 19:12
https://xconomy.com/san-diego/2019/02/13/autonomous-truck-company-tusimple-adds-95m-to-rev-up-commercial-fleet/60%Monthly2019-02-14 13:48
https://xconomy.com/seattle/2019/02/12/why-did-amazon-buy-eero-wi-fi-users-covet-simplicity-security/60%Monthly2019-02-12 23:26
https://xconomy.com/national/2019/02/12/losing-scalps-despite-pharma-fear-a-split-on-trump-rx-price-plans/60%Monthly2019-02-12 23:32
https://xconomy.com/new-york/2019/02/12/neurogene-names-stuart-cobb-chief-scientific-officer/60%Monthly2019-02-12 21:33
https://xconomy.com/san-francisco/2019/02/12/graybug-vision-taps-ex-novartis-exec-guerard-for-ceo-post/60%Monthly2019-02-12 21:28
https://xconomy.com/detroit-ann-arbor/2019/02/12/may-mobility-snags-22m-investment-will-expand-to-new-cities-in-19/60%Monthly2019-02-12 20:38
https://xconomy.com/new-york/2019/02/12/neurogene-emerges-with-68m-to-advance-gene-therapies-to-the-clinic/60%Monthly2019-02-12 18:24
https://xconomy.com/seattle/2019/02/11/providence-st-joseph-acquires-seattle-blockchain-startup-lumedic/60%Monthly2019-02-12 01:52
https://xconomy.com/boston/2019/02/11/endeavor-robotics-flir-systems-military-unmanned-systems-drones/60%Monthly2019-02-12 13:40
https://xconomy.com/san-francisco/2019/02/11/meeting-low-expectations-gileads-top-nash-drug-fails-1st-major-test/60%Monthly2019-02-12 05:12
https://xconomy.com/texas/2019/02/11/houston-health-it-firm-decisio-forms-partnership-with-ge-healthcare/60%Monthly2019-02-12 13:41
https://xconomy.com/texas/2019/02/11/san-antonio-life-science-business-acelity-cuts-260-jobs-in-texas-nc/60%Monthly2019-02-11 23:52
https://xconomy.com/new-york/2019/02/11/abeona-therapeutics-ceo-joao-siffert-sheds-interim-title/60%Monthly2019-02-12 13:54
https://xconomy.com/san-francisco/2019/02/11/abbvie-joins-myeloma-race-with-90m-deal-for-rights-to-teneobio-drug/60%Monthly2019-02-11 21:44
https://xconomy.com/san-diego/2019/02/11/qualcomm-sells-medical-device-connectivity-business-to-pe-firm/60%Monthly2019-02-11 21:12
https://xconomy.com/detroit-ann-arbor/2019/02/11/roundup-riser-leaving-techtown-stem-summit-u-m-av-news-and-more/60%Monthly2019-02-12 02:37
https://xconomy.com/texas/2019/02/11/emergency-services-cloud-software-maker-rapiddeploy-nets-12m/60%Monthly2019-02-11 17:55
https://xconomy.com/san-francisco/2019/02/11/gv-taps-ex-agios-ceo-schenkein-to-lead-life-science-investments/60%Monthly2019-02-11 17:52
https://xconomy.com/new-york/2019/02/11/matching-amgen-regeneron-to-cut-list-price-of-heart-drug-by-60/60%Monthly2019-02-11 12:30
https://xconomy.com/seattle/2019/02/08/stably-tacks-on-1-2m-to-reduce-volatility-in-digital-currencies/60%Monthly2019-02-08 22:48
https://xconomy.com/wisconsin/2019/02/08/bain-capital-backs-imagemovermds-medical-image-management-tools/60%Monthly2019-02-08 22:53
https://xconomy.com/boston/2019/02/08/datarobot-machine-learning-grammy-awards-song-of-the-year/60%Monthly2019-02-08 21:11
https://xconomy.com/detroit-ann-arbor/2019/02/08/french-auto-supplier-valeo-moves-toward-mobility-with-new-innovations/60%Monthly2019-02-08 20:38
https://xconomy.com/national/2019/02/08/bio-roundup-new-crispr-feud-a-ny-splash-pharma-vs-congress-more/60%Monthly2019-02-08 11:48
https://xconomy.com/boston/2019/02/08/boston-tech-watch-boston-dynamics-wework-optimus-ride-hydrow/60%Monthly2019-02-08 01:56
https://xconomy.com/detroit-ann-arbor/2019/02/08/genomenon-raises-2-5m-plans-to-increase-work-with-pharma-customers/60%Monthly2019-02-07 21:03
https://xconomy.com/wisconsin/2019/02/08/wi-watchlist-epic-systems-m-werc-nordic-dianomi-therapeutics/60%Monthly2019-02-07 21:40
https://xconomy.com/san-diego/2019/02/07/gossamer-bio-adds-276m-in-second-biotech-unicorn-ipo-of-2019/60%Monthly2019-02-08 02:25
https://xconomy.com/boston/2019/02/07/carbonite-buys-webroot-for-618m-to-offer-security-with-a-safety-net/60%Monthly2019-02-08 14:26
https://xconomy.com/san-francisco/2019/02/07/harpoons-ipo-spears-76m-as-prostate-cancer-drug-continues-testing/60%Monthly2019-02-08 02:04
https://xconomy.com/seattle/2019/02/07/boeing-is-aerions-latest-partner-in-supersonic-passenger-jet-effort/60%Monthly2019-02-07 22:58
https://xconomy.com/san-francisco/2019/02/07/in-landmark-gene-editing-study-sangamo-reports-little-benefit/60%Monthly2019-02-07 20:38
https://xconomy.com/texas/2019/02/07/hypergiant-in-space-celltex-saudi-siete-foods-90m-more-tx-tech/60%Monthly2019-02-07 18:13
https://xconomy.com/texas/2019/02/07/inventa-biotech-formerly-cytobioscience-replaces-ceo/60%Monthly2019-02-07 19:28
https://xconomy.com/boston/2019/02/07/seres-lays-off-30-of-staff-cso-leaves-after-pipeline-review/60%Monthly2019-02-07 17:43
https://xconomy.com/boston/2019/02/07/irobot-trade-war-takes-8m-toll-fuels-decision-to-leave-china/60%Monthly2019-02-07 22:52
https://xconomy.com/wisconsin/2019/02/07/fasetto-downloads-6m-for-connected-devices-and-cloud-tools/60%Monthly2019-02-07 15:51
https://xconomy.com/seattle/2019/02/07/kensci-gets-22m-for-tools-to-help-hospitals-flag-high-risk-patients/60%Monthly2019-02-07 16:20
https://xconomy.com/boston/2019/02/07/notary-startup-notarize-wayfair-hubspot-chief-operating-officer/60%Monthly2019-02-07 13:59
https://xconomy.com/boston/2019/02/07/with-its-first-human-data-solid-slips-in-duchenne-gene-therapy-race/60%Monthly2019-02-07 16:56
https://xconomy.com/new-york/2019/02/07/with-60m-for-hibercell-nycedc-finally-puts-its-ny-bio-fund-to-work/60%Monthly2019-02-07 11:17
https://xconomy.com/detroit-ann-arbor/2019/02/07/everdays-raises-12-million-for-end-of-life-communication-platform/60%Monthly2019-02-07 18:48
https://xconomy.com/san-francisco/2019/02/06/alector-ipo-banks-176m-to-test-alzheimers-drugs-in-clinical-trials/60%Monthly2019-02-07 02:22
https://xconomy.com/san-francisco/2019/02/06/new-crispr-fight-old-friends-intellia-caribou-in-license-dispute/60%Monthly2019-02-06 20:28
https://xconomy.com/texas/2019/02/06/foot-traffic-startup-scraffic-mulls-new-funding-machine-learning/60%Monthly2019-02-15 16:53
https://xconomy.com/raleigh-durham/2019/02/06/chimerix-executive-michelle-berrey-resigns-as-ceo-board-member/60%Monthly2019-02-06 17:53
https://xconomy.com/boston/2019/02/06/frequency-chief-medical-officer-weber-jumps-to-decibel-therapeutics/60%Monthly2019-02-06 17:47
https://xconomy.com/san-diego/2019/02/06/halozyme-gets-30m-from-argenx-in-licensing-deal-worth-up-to-530m/60%Monthly2019-02-06 16:49
https://xconomy.com/texas/2019/02/06/houston-investors-step-up-to-bring-tech-innovation-to-the-energy-sector/60%Monthly2019-02-07 19:15
https://xconomy.com/seattle/2019/02/05/helmet-maker-vicis-courts-nfl-qbs-to-invest-in-latest-funding-round/60%Monthly2019-02-06 06:31
https://xconomy.com/san-francisco/2019/02/05/bolt-bio-bags-54m-for-drugs-that-turn-the-heat-up-on-cold-tumors/60%Monthly2019-02-05 20:44
https://xconomy.com/new-york/2019/02/05/lauring-leaves-takeda-for-chief-medical-officer-post-at-kallyope/60%Monthly2019-02-05 16:11
https://xconomy.com/detroit-ann-arbor/2019/02/05/health-analytics-supergroup-crunches-data-to-speed-drug-development/60%Monthly2019-02-05 16:03
https://xconomy.com/boston/2019/02/05/cyber-madness-case-studies-in-security/60%Monthly2019-02-06 23:38
https://xconomy.com/texas/2019/02/05/connected-car-firm-vinli-raises-13-5m-partners-with-germanys-e-on/60%Monthly2019-02-05 16:28
https://xconomy.com/san-diego/2019/02/04/cancer-cures-and-the-importance-of-communicating-responsibly/60%Monthly2019-02-05 17:55
https://xconomy.com/san-diego/2019/02/04/maxwell-struggling-battery-technology-maker-to-sell-to-tesla/60%Monthly2019-02-05 03:51
https://xconomy.com/san-francisco/2019/02/04/privacy-watch-facebook-rebounds-but-privacy-concerns-accelerate/60%Monthly2019-02-05 16:29
https://xconomy.com/boston/2019/02/04/zoominfo-acquired-business-intelligence-vancouver-discoverorg/60%Monthly2019-02-05 14:17
https://xconomy.com/boston/2019/02/04/sojournix-appoints-ruth-thieroff-ekerdt-chief-medical-officer/60%Monthly2019-02-04 23:39
https://xconomy.com/seattle/2019/02/04/microsoft-buys-cloud-service-datasense-to-expand-education-suite/60%Monthly2019-02-04 22:53
https://xconomy.com/boston/2019/02/04/minim-expands-wi-fi-security-tool-to-wisps-with-deal-for-aerez/60%Monthly2019-02-04 19:03
https://xconomy.com/texas/2019/02/04/new-funds-for-goco-cherrycircle-phynd-hive9-more-tx-tech/60%Monthly2019-02-04 15:45
https://xconomy.com/national/2019/02/04/xconomy-awards-san-diego-nominations-deadline-extended-to-feb-7/60%Monthly2019-01-31 20:44
https://xconomy.com/wisconsin/2019/02/03/george-mosher-milwaukee-startup-investor-philanthropist-has-died/60%Monthly2019-02-03 20:36
https://xconomy.com/boston/2019/02/01/fda-rejects-alkermes-depression-drug-asks-for-more-clinical-data/60%Monthly2019-02-01 23:57
https://xconomy.com/seattle/2019/02/01/seattle-venture-capital-watch-alpine-immune-wyze-aduro-gaia-more/60%Monthly2019-02-01 22:18
https://xconomy.com/seattle/2019/02/01/allen-institute-adds-peterson-hackett-to-executive-team/60%Monthly2019-02-01 20:32
https://xconomy.com/texas/2019/02/01/lgs-innovations-plans-san-antonio-cyber-hub-after-750m-sale-to-caci/60%Monthly2019-02-04 20:02
https://xconomy.com/seattle/2019/02/01/magnolia-medical-captures-20m-to-reduce-blood-culture-contamination/60%Monthly2019-02-01 17:15
https://xconomy.com/texas/2019/02/01/billygo-app-aims-to-provide-plumbers-on-tap-within-an-hour/60%Monthly2019-02-02 14:51
https://xconomy.com/detroit-ann-arbor/2019/02/01/global-detroit-pushes-back-on-trumps-immigration-proposals/60%Monthly2019-02-01 13:55
https://xconomy.com/national/2019/02/01/bio-roundup-alzheimers-fail-drug-price-plan-gene-therapies-more/60%Monthly2019-02-01 11:58
https://xconomy.com/boston/2019/02/01/boston-tech-watch-scooters-toast-mimecast-atscale-acquia-more/60%Monthly2019-01-31 22:19
https://xconomy.com/san-francisco/2019/01/31/aleksandra-rizo-departs-celgene-for-geron-chief-medical-post/60%Monthly2019-02-01 04:16